Darunavir Ethanolate (Prezista) is an inhibitor of HIV protease. Darunavir was designed to form robust interactions with the protease enzyme from many strains of HIV, including strains from treatment-experienced patients with multiple resistance mutations to PIs.
|Body Surface Area (m2)||0.007||0.025||0.15||0.05||0.02||0.5|
|Animal A (mg/kg) = Animal B (mg/kg) multiplied by||Animal B Km|
|Animal A Km|
For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.
|Solubility||DMSO 100 mg/mL|
|Source||AAPS PharmSciTech (2017). Figure 7.Darunavir Ethanolate|
|Cell Lines||Wistar rats|
|Incubation Time||0.5, 1, 2, 4, 8, and 24 h|
|Results||The plasma concentration of darunavir in rats after oral administration of SLNs and peptide-grafted SLNs showed no significant difference (P > 0.5).|
|Source||AAPS PharmSciTech (2017). Figure 4.Darunavir Ethanolate|
|Method||Identification of Internalization Pathway|
|Cell Lines||Caco-2 cell line|
|Incubation Time||0.5, 1, 2, 3, and 4 h|
|Results||The relative uptake efficiency of darunavir in presence of endocytic inhibitors is graphically depicted in Fig. 4.|
The fate of ritonavir in the presence of darunavir.
Nguyen DN, et al. Int J Pharm. 2014 Nov 20;475(1-2):214-26. PMID: 25180992.
Hepatobiliary and intestinal elimination of darunavir in an integrated preclinical rat model.
Stappaerts J, et al. Xenobiotica. 2014 Jun;44(6):489-97. PMID: 24274355.
|Related HIV Protease Products|
Darunavir is a nonpeptidic HIV protease inhibitor, used to treat HIV infection.
Saquinavir mesylate is an HIV Protease Inhibitor used in antiretroviral therapy.
Saquinavir(Ro 31-8959) is an HIV Protease inhibitor used in antiretroviral therapy.
Atazanavir is an azapeptide and HIV-protease inhibitor that is used in the treatment of HIV infections and AIDS in combination with other anti-HIV agents.
Dolutegravir sodium is a potent, second generation HIV integrase inhibitor (IC₅₀ = 2.7 nM) that displays potent antiviral activity.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2017 AbMole BioScience. All Rights Reserved.